80 related articles for article (PubMed ID: 9183668)
1. [Establishment of a new human ovarian serous cystadenocarcinoma cell line (IM), and influence on cell proliferations by cisplatin with or without hyperthermia].
Iida T; Yoshida N; Kuramoto H; Shimoda T; Hamano M; Hata H; Yonamine K; Hayashi K
Hum Cell; 1996 Dec; 9(4):345-52. PubMed ID: 9183668
[TBL] [Abstract][Full Text] [Related]
2. [Establishment of a cisplatin-resistant human ovarian cancer cell line].
Sasa H; Hisano A; Ishii K; Hirata J; Kikuchi Y; Nagata I; Senoo A; Aida S; Tamai S; Sugita M
Hum Cell; 1993 Jun; 6(2):106-13. PubMed ID: 8217948
[TBL] [Abstract][Full Text] [Related]
3. In vitro test-system for chemo- and thermosensitivity: an analysis of survival fractions and cell-cycle distributions in human Ewing's sarcomas as a modelfor tumors in pediatric oncology.
Debes A; Rommel F; Breise M; Willers R; Göbel U; Wessalowski R
Klin Padiatr; 2002; 214(4):223-9. PubMed ID: 12165906
[TBL] [Abstract][Full Text] [Related]
4. [Cancer chemo-endocrine therapy and its cell biological basis].
Nishiya I
Hum Cell; 1998 Sep; 11(3):109-14. PubMed ID: 10086273
[TBL] [Abstract][Full Text] [Related]
5. [Cytokinetic effects of cisplatin on cisplatin-resistant ovarian cancer cell lines].
Sasa H; Kikuchi Y; Hisano A; Ishii K; Nagata I; Kawai T; Aida S; Sugita M; Sugishita T; Tenjin Y
Hum Cell; 1992 Dec; 5(4):384-91. PubMed ID: 1304801
[TBL] [Abstract][Full Text] [Related]
6. Establishment and characterization of cell lines derived from serous adenocarcinoma (JHOS-2) and clear cell adenocarcinoma (JHOC-5, JHOC-6) of human ovary.
Yamada K; Tachibana T; Hashimoto H; Suzuki K; Yanagida S; Endoh H; Kimura E; Yasuda M; Tanaka T; Ishikawa H
Hum Cell; 1999 Sep; 12(3):131-8. PubMed ID: 10695020
[TBL] [Abstract][Full Text] [Related]
7. Determination of potential doubling times in human melanoma cell cultures subjected to irradiation and/or hyperthermia by flow cytometry.
Zölzer F; Devi PU; Streffer C
Radiat Res; 1994 Jun; 138(3):451-9. PubMed ID: 8184021
[TBL] [Abstract][Full Text] [Related]
8. [Cytokinetic effects of carboplatin and cisplatin on a human ovarian cancer cell line].
Yoshizumi N; Fujiwara J; Yoshizaki A; Sato M; Sakai R; Nishiya I
Hum Cell; 1988 Sep; 1(3):301-7. PubMed ID: 2979207
[TBL] [Abstract][Full Text] [Related]
9. [Establishment of a cisplatin-resistant human ovarian cancer cell line and the mechanism of resistance].
Kikuchi Y; Iwano I; Miyauchi M; Kita T; Kizawa I; Oomori K; Kato K
Nihon Sanka Fujinka Gakkai Zasshi; 1988 Mar; 40(3):379-83. PubMed ID: 3361190
[TBL] [Abstract][Full Text] [Related]
10. [Borderline ovarian tumors].
Ivanov S
Akush Ginekol (Sofiia); 2002; 42(1):23-5. PubMed ID: 11935694
[TBL] [Abstract][Full Text] [Related]
11. [The dose-response of cell proliferation and secretion of CA125 II antigen to follicle stimulating hormone in ovarian cancer cell lines].
Zhu M; Wu Q; Ge B
Zhonghua Fu Chan Ke Za Zhi; 1998 Apr; 33(4):225-6. PubMed ID: 10682470
[TBL] [Abstract][Full Text] [Related]
12. [Drug resistant mechanisms of platinum derivatives in a human cisplatin resistant ovarian cancer cell line].
Nishiya I; Yoshizumi N; Fujiwara J; Kagabu T
Gan To Kagaku Ryoho; 1988 Oct; 15(10):2871-81. PubMed ID: 3178236
[TBL] [Abstract][Full Text] [Related]
13. Characterization of a cell line derived from the ascites of a patient with papillary serous cystadenocarcinoma of the ovary.
Wilson AP
J Natl Cancer Inst; 1984 Mar; 72(3):513-21. PubMed ID: 6583437
[TBL] [Abstract][Full Text] [Related]
14. [Establishment and characterization of a CA125-producing human ovarian clear cell carcinoma cell line].
Sasa H; Ishii K; Hirata J; Kikuchi Y; Nagata I; Kawai T; Senoo A; Sugita M; Sugishita T; Tenjin Y
Hum Cell; 1993 Dec; 6(4):279-86. PubMed ID: 8148309
[TBL] [Abstract][Full Text] [Related]
15. Establishment and characterization of three new cell lines derived from the ascites of human ovarian carcinomas.
Alama A; Barbieri F; Favre A; Cagnoli M; Noviello E; Pedullà F; Viale M; Foglia G; Ragni N
Gynecol Oncol; 1996 Jul; 62(1):82-8. PubMed ID: 8690298
[TBL] [Abstract][Full Text] [Related]
16. Demonstration of an S phase population of cells without DNA synthesis generated by cisplatin and pentoxifylline.
Perras JP; Ramos R; Sevin BU
Cytometry; 1993; 14(4):441-8. PubMed ID: 8513698
[TBL] [Abstract][Full Text] [Related]
17. CA125 regression during neoadjuvant chemotherapy as an independent prognostic factor for survival in patients with advanced ovarian serous adenocarcinoma.
Tate S; Hirai Y; Takeshima N; Hasumi K
Gynecol Oncol; 2005 Jan; 96(1):143-9. PubMed ID: 15589593
[TBL] [Abstract][Full Text] [Related]
18. Characterization of newly established cell line HUOA from a human ovarian serous cystadenocarcinoma.
Ishiwata I; Ishiwata C; Kobayashi N; Ishikawa H
Nihon Sanka Fujinka Gakkai Zasshi; 1987 May; 39(5):831-6. PubMed ID: 3598277
[TBL] [Abstract][Full Text] [Related]
19. [Experimental study on the mechanism of cisplatin resistance and its reversion in human ovarian cancer].
Liang Z; Bian D
Zhonghua Fu Chan Ke Za Zhi; 1996 Feb; 31(2):75-8. PubMed ID: 8758797
[TBL] [Abstract][Full Text] [Related]
20. Characterization of mitochondria in cisplatin-resistant human ovarian carcinoma cells.
Hirama M; Isonishi S; Yasuda M; Ishikawa H
Oncol Rep; 2006 Nov; 16(5):997-1002. PubMed ID: 17016583
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
